Ultrafast myocardial contrast echocardiography shows early potential to evaluate CAD

Ultrafast/high frame rate myocardial contrast echocardiography

Conventional myocardial contrast echocardiography images on the left. Ultrafast/high frame rate myocardial contrast echocardiography images on the right. Images courtesy of Circulation: Cardiovascular Imaging and Gvinianidze et al.

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Turning Heart Failure into Heart Success: Integrating Barostim into a Comprehensive Heart Failure Program

Despite the use of effective drug and device therapies, many patients with HFrEF continue to experience worsening symptoms and disease progression. Barostim is a novel device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Most importantly, 94% of patients receiving the device had significant improvement in quality of life, exercise capacity or functional status heart failure symptoms.(1)